Ethex initiates precautionary drug recall

The U.S. Food and Drug Administration announced the recall of three lots of Dextroamphetamine Sulfate 5 mg tablets due to a possible tablet size problem.

The FDA said the Ethex Corp. of St. Louis initiated the precautionary recall of lots 77946, 81141 and 81142 of the psychostimulant because of the possible presence of oversized tablets that might contain as much as twice the labeled amount of the active ingredient.

The recalled lots were distributed under the "Ethex" label between January 2007 and May 2008. The 5 mg product is an orange round tablet embossed with "ETHEX" and "311" on one side.

Officials noted there are multiple U.S. companies producing and marketing generic versions of Dextroamphetamine Sulfate 5 mg tablets and consumers and their caregivers are encouraged to check their prescriptions to determine the source of their tablets.

Consumers with questions can contact Ethex at 800-321-1705.